Shionogi & Co Ltd (4507) - Financial and Strategic SWOT Analysis Review

Shionogi & Co Ltd (4507) - Financial and Strategic SWOT Analysis Review

  • Products Id :- GDPH2619FSA
  • |
  • Pages: 58
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Shionogi & Co Ltd (4507)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.


Shionogi & Co Ltd (Shionogi) focuses on the research, development, manufacturing and marketing of pharmaceutical products, diagnostic reagents and medical devices. The company's core pharmaceuticals product business offers drugs for the treatment of disorders in the areas of metabolism, infection, immunity and cancer pain. Shionogi also sells, distributes and provides information about diagnostic products in the fields of infectious diseases, cardiovascular diseases and allergies. The company operates a network of subsidiaries, branches, sales offices manufacturing plants and research laboratories across Japan, China, Taiwan, North America and Europe. Shionogi is headquartered in Osaka, Japan.

Shionogi & Co Ltd Key Recent Developments

Sep 05,2018: Baloxavir Marboxil Phase II and III Studies for the Treatment of Influenza Published in the New England Journal of Medicine[Newswire : Healthcare-BW]

Aug 30,2018: TOPC : Shionogi Announces U.S. Availability of Mulpleta (Lusutrombopag) for the Treatment of Thrombocytopenia in Adults with Chronic Liver Disease Scheduled to Undergo a Procedure[TPS : Biospace]

Jul 30,2018: Shionogi: Financial Results for the First Quarter of Fiscal Year 2018(Consolidated)

Jul 13,2018: Flu diagnosis kit 'BRIGHTPOC FluNeo' launched in Japan

May 09,2018: Shionogi : Financial Results for Fiscal Year 2017

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

Shionogi & Co Ltd-Key Facts 6

Shionogi & Co Ltd-Key Employees 7

Shionogi & Co Ltd-Key Employee Biographies 10

Shionogi & Co Ltd-Major Products and Services 11

Shionogi & Co Ltd-History 13

Shionogi & Co Ltd-Company Statement 21

Shionogi & Co Ltd-Locations And Subsidiaries 22

Head Office 22

Other Locations & Subsidiaries 22

Joint Venture 24

Section 2-Company Analysis 25

Company Overview 25

Shionogi & Co Ltd-Business Description 26

Shionogi & Co Ltd-Corporate Strategy 27

Shionogi & Co Ltd-SWOT Analysis 28

SWOT Analysis-Overview 28

Shionogi & Co Ltd-Strengths 28

Shionogi & Co Ltd-Weaknesses 29

Shionogi & Co Ltd-Opportunities 30

Shionogi & Co Ltd-Threats 31

Shionogi & Co Ltd-Key Competitors 32

Section 3-Company Financial Ratios 33

Financial Ratios-Capital Market Ratios 33

Financial Ratios-Annual Ratios 34

Performance Chart 37

Financial Performance 37

Financial Ratios-Interim Ratios 38

Financial Ratios-Ratio Charts 39

Section 4-Company's Lifesciences Financial Deals and Alliances 40

Shionogi & Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 40

Shionogi & Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 41

Shionogi & Co Ltd, Recent Deals Summary 42

Section 5-Company's Recent Developments 43

Jul 30, 2018: Shionogi: Financial Results for the First Quarter of Fiscal Year 2018(Consolidated) 43

Jul 13, 2018: Flu diagnosis kit 'BRIGHTPOC Flu?Neo' launched in Japan 44

May 09, 2018: Shionogi : Financial Results for Fiscal Year 2017 45

Mar 22, 2018: Shionogi Announces Agreement with CARB-X for an Innovative AMR (Anti Microbial Resistance) Program 47

Mar 19, 2018: Shionogi to Announce Executive Appointments 48

Feb 28, 2018: Shionogi to Announce Corporate Reorganizations 49

Feb 05, 2018: Shionogi: Financial Results for the Third Quarter of Fiscal Year 2017(Consolidated) 50

Oct 13, 2017: The Dispute with the Boards of Appeal of the European Patent Office between Merck & Co., Inc. regarding HIV integrase inhibitor 51

Sep 21, 2017: Shionogi to Announce Personnel Reassignment 52

Jul 31, 2017: Shionogi Reports Revenue Of JPY75 Billion In Q1 Fiscal 2018 53

Section 6-Appendix 54

Methodology 54

Ratio Definitions 54

About GlobalData 58

Contact Us 58

Disclaimer 58

List of Figures

Shionogi & Co Ltd, Performance Chart (2014-2018) 37

Shionogi & Co Ltd, Ratio Charts 39

Shionogi & Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 40

Shionogi & Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 41

List of Tables

Shionogi & Co Ltd, Key Facts 6

Shionogi & Co Ltd, Key Employees 7

Shionogi & Co Ltd, Key Employee Biographies 10

Shionogi & Co Ltd, Major Products and Services 11

Shionogi & Co Ltd, History 13

Shionogi & Co Ltd, Other Locations 22

Shionogi & Co Ltd, Subsidiaries 23

Shionogi & Co Ltd, Joint Venture 24

Shionogi & Co Ltd, Key Competitors 32

Shionogi & Co Ltd, Ratios based on current share price 33

Shionogi & Co Ltd, Annual Ratios 34

Shionogi & Co Ltd, Annual Ratios (Cont...1) 35

Shionogi & Co Ltd, Annual Ratios (Cont...2) 36

Shionogi & Co Ltd, Interim Ratios 38

Shionogi & Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 40

Shionogi & Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 41

Shionogi & Co Ltd, Recent Deals Summary 42

Currency Codes 54

Capital Market Ratios 54

Equity Ratios 55

Profitability Ratios 55

Cost Ratios 56

Liquidity Ratios 56

Leverage Ratios 57

Efficiency Ratios 57

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@]

Chugai Pharmaceutical Co Ltd

Daiichi Sankyo Co Ltd

Otsuka Pharmaceutical Co Ltd

Santen Pharmaceutical Co Ltd

Takeda Pharmaceutical Co Ltd

Shionogi & Co Ltd, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license
Single User License
USD 125 INR 8905
Site License
USD 250 INR 17810
Corporate User License
USD 375 INR 26715



The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@]